LONDON, June 1 (Reuters) – British newspapers reported the following business stories on Sunday. Reuters has not independently verified these media reports and does not vouch for their accuracy.
Continue Reading On http://www.reuters.com »
– http://www.reuters.com/healthNews
CHICAGO (Reuters) – The estrogen-blocking drug Aromasin worked better than the long-standing therapy tamoxifen at keeping cancers from returning in younger women with early stage breast cancer, a finding that may change the way the patients are treated, U.S. researchers said on Sunday.
Continue Reading On http://www.reuters.com/healthNews »
– http://www.reuters.com/healthNews
ZURICH (Reuters) – An experimental drug from Novartis markedly shrank tumors in patients with advanced basal cell carcinoma, the most common form of skin cancer, according to the results of a mid-stage study published on Sunday.
Continue Reading On http://www.reuters.com/healthNews »
DUBLIN, Ohio, May 31 (Reuters) – If golf star Phil Mickelson is concerned by a federal probe into possible insider trading involving him, billionaire investor Carl Icahn and Las Vegas gambler William Walters, he did not show it on Saturday.
Continue Reading On http://www.reuters.com »
CHICAGO, May 31 (Reuters) – A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday.
Continue Reading On http://www.reuters.com »
CHICAGO, June 1 (Reuters) – The estrogen-blocking drug Aromasin worked better than the long-standing therapy tamoxifen at keeping cancers from returning in younger women with early stage breast cancer, a finding that may change the way the patients are treated, U.S. researchers said on Sunday.
Continue Reading On http://www.reuters.com »
No down payment medical, dental and healthcare provider practice financing here! + More News: PRESS DIGEST-SUNDAY BRITISH BUSINESS-JUN 1 + MORE 06/01/2014
No comments:
Post a Comment